Filter posts

JOBS Act Deconstructed: Regulation A

More than 40 biotech companies have gone public using provisions made available to emerging growth …

BIO Investor Forum to Showcase NSF-funded Companies

No risk, no reward—that’s the concept driving the startups and entrepreneurs scheduled to present at …

JOBS Act Deconstructed: Regulatory Relief

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Deconstructed: Regulation D

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Provides Innovators with Capital Boost

Despite all the talk of gridlock and polarization in Washington these days, successful, bipartisan pieces …

Propel Small Business Innovation through Tax Reform

As CEO of an emerging clinical-stage biotech company, I lose over $10 million each year. …

The Pivotal Role the Public Market Plays in Financing R&D

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle …

Crowdfunding Goes Viral

Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are …

Small Biotech Companies and China: 5 Keys to Success

Big pharmaceutical countries aren’t the only ones investing in China. Emerging and mid-sized biotech companies are also …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …